Mycenax Biotech is a Taiwanese CDMO that has a wealth of experience in developing biologics, including small peptides, fusion proteins, and monoclonal antibodies. The company is proficient in cell line development (CHO, Sp2/0, E. coli), process development, formulation, analytical methods, GMP manufacturing, and fill/finish.